Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) EVP Eugene Schneider sold 6,179 shares of the company’s stock in a transaction on Friday, January 30th. The shares were sold at an average price of $83.45, for a total transaction of $515,637.55. Following the completion of the sale, the executive vice president directly owned 69,702 shares […]

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) EVP C Frank Bennett sold 5,885 shares of the business’s stock in a transaction dated Friday, January 30th. The stock was sold at an average price of $82.95, for a total transaction of $488,160.75. Following the completion of the transaction, the executive vice president owned 100,293 shares […]

Milestone Pharmaceuticals Inc. (NASDAQ:MIST – Get Free Report) CEO Joseph Oliveto sold 34,523 shares of the firm’s stock in a transaction on Monday, January 26th. The shares were sold at an average price of $1.93, for a total value of $66,629.39. Following the completion of the sale, the chief executive officer directly owned 482,744 shares […]

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) CEO Christopher Peetz sold 6,831 shares of the firm’s stock in a transaction on Monday, January 26th. The stock was sold at an average price of $96.19, for a total transaction of $657,073.89. Following the completion of the sale, the chief executive officer directly owned 169,402 shares […]

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Free Report) CAO James George Chopas sold 726 shares of the stock in a transaction that occurred on Tuesday, January 20th. The stock was sold at an average price of $19.79, for a total value of $14,367.54. Following the transaction, the chief accounting officer directly owned 51,869 shares of […]

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) EVP Shannon Devers sold 3,977 shares of the business’s stock in a transaction dated Thursday, January 22nd. The stock was sold at an average price of $81.34, for a total value of $323,489.18. Following the completion of the transaction, the executive vice president directly owned 22,541 shares […]

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Free Report) CAO James George Chopas sold 2,064 shares of the firm’s stock in a transaction on Thursday, January 22nd. The shares were sold at an average price of $21.77, for a total transaction of $44,933.28. Following the completion of the transaction, the chief accounting officer directly owned 49,805 […]

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Free Report) CFO Timothy Eugene Sullivan sold 10,287 shares of Apellis Pharmaceuticals stock in a transaction dated Thursday, January 22nd. The stock was sold at an average price of $21.77, for a total transaction of $223,947.99. Following the sale, the chief financial officer directly owned 93,901 shares of the […]

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Get Free Report) CEO Joshua Cohen sold 136,193 shares of the business’s stock in a transaction on Thursday, January 15th. The stock was sold at an average price of $13.59, for a total value of $1,850,862.87. Following the completion of the transaction, the chief executive officer directly owned 3,378,546 shares […]

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) EVP Eugene Schneider sold 9,302 shares of the firm’s stock in a transaction on Friday, January 16th. The stock was sold at an average price of $75.59, for a total value of $703,138.18. Following the completion of the transaction, the executive vice president directly owned 63,890 shares […]

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) EVP C Frank Bennett sold 8,977 shares of Ionis Pharmaceuticals stock in a transaction on Friday, January 16th. The stock was sold at an average price of $75.15, for a total transaction of $674,621.55. Following the transaction, the executive vice president directly owned 94,757 shares of the […]

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) CEO Brett Monia sold 44,034 shares of the firm’s stock in a transaction on Friday, January 16th. The stock was sold at an average price of $74.82, for a total transaction of $3,294,623.88. Following the sale, the chief executive officer owned 224,683 shares in the company, valued […]